GUANFACINE HYDROCHLORIDE | A205430 | APOTEX INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2013-11-21 | Terminated 2014-04-07 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.1816
per ea
Lowest NADAC/Unit
$0.1323
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 60505393001GUANFACINE HCL ER 4 MG TABLET | $0.1816 | EA | Generic | — | 2026-10-21 |
| 60505392901GUANFACINE HCL ER 3 MG TABLET | $0.1756 | EA | Generic | — | 2026-10-21 |
| 60505392801GUANFACINE HCL ER 2 MG TABLET | $0.1486 | EA | Generic | — | 2026-10-21 |
| 60505392701GUANFACINE HCL ER 1 MG TABLET | $0.1323 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.